ClinicalTrials.govpublic full text
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
crohn's disease, rifaximin, clinical remission with endoscopic response, inflammatory bowel disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896674
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.